BRPI0821002A2 - Compostos e métodos para o tratamento de câncer - Google Patents
Compostos e métodos para o tratamento de câncerInfo
- Publication number
- BRPI0821002A2 BRPI0821002A2 BRPI0821002-0A BRPI0821002A BRPI0821002A2 BR PI0821002 A2 BRPI0821002 A2 BR PI0821002A2 BR PI0821002 A BRPI0821002 A BR PI0821002A BR PI0821002 A2 BRPI0821002 A2 BR PI0821002A2
- Authority
- BR
- Brazil
- Prior art keywords
- methods
- cancer treatment
- treatment compounds
- compounds
- cancer
- Prior art date
Links
- 206010028980 Neoplasm Diseases 0.000 title 1
- 201000011510 cancer Diseases 0.000 title 1
- 150000001875 compounds Chemical class 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/66—Arsenic compounds
- C07F9/70—Organo-arsenic compounds
- C07F9/72—Aliphatic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/66—Arsenic compounds
- C07F9/70—Organo-arsenic compounds
- C07F9/80—Heterocyclic compounds
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Hematology (AREA)
- Oncology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US737107P | 2007-12-12 | 2007-12-12 | |
| PCT/US2008/013620 WO2009075870A1 (en) | 2007-12-12 | 2008-12-12 | Compounds and methods for the treatment of cancer |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BRPI0821002A2 true BRPI0821002A2 (pt) | 2015-06-16 |
Family
ID=40755796
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BRPI0821002-0A BRPI0821002A2 (pt) | 2007-12-12 | 2008-12-12 | Compostos e métodos para o tratamento de câncer |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US20100331403A1 (pt) |
| EP (1) | EP2231684A4 (pt) |
| JP (2) | JP5600597B2 (pt) |
| KR (1) | KR20100097679A (pt) |
| CN (2) | CN104592302A (pt) |
| AU (1) | AU2008335705A1 (pt) |
| BR (1) | BRPI0821002A2 (pt) |
| CA (1) | CA2705467A1 (pt) |
| HK (1) | HK1209754A1 (pt) |
| IL (1) | IL205339A0 (pt) |
| SG (1) | SG186599A1 (pt) |
| WO (1) | WO2009075870A1 (pt) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2019075507A1 (en) * | 2017-10-17 | 2019-04-25 | University Of Wollongong | ANTICANCER AGENT |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2349729A (en) * | 1940-08-24 | 1944-05-23 | Parke Davis & Co | Therapeutic arsenic preparation |
| EP1419778A1 (en) * | 1997-10-15 | 2004-05-19 | Polarx Biopharmaceuticals, Inc. | Compositions and methods for the treatment of primary and metastatic neoplastic diseases using arsenic compounds |
| DK2255800T3 (da) * | 1997-11-10 | 2013-02-04 | Sloan Kettering Inst Cancer | Arsentrioxid til anvendelse ved behandling af leukæmi |
| CN1233476A (zh) * | 1998-04-24 | 1999-11-03 | 陆道培 | 治疗急性白血病的药物及其制备方法 |
| US6191123B1 (en) * | 1999-03-19 | 2001-02-20 | Parker Hughes Institute | Organic-arsenic compounds |
| ATE320793T1 (de) * | 2000-04-26 | 2006-04-15 | Univ Oregon Health Sciences | Verabreichung von einer chemoschützenden verbindung,welche eine thiolgruppe enthält |
| EP2462932A1 (en) * | 2002-01-07 | 2012-06-13 | Board Of Regents, The University Of Texas System | S-dimethylarsino-thiosuccinic acid s-dimethylarsino-2-thiobenzoic acid s-(dimethylarsino) glutathione as treatments for cancer |
| TW201440760A (zh) * | 2004-07-16 | 2014-11-01 | Texas A & M Univ Sys | 有機砷化合物、其用於治療癌症之用途及包含其之醫藥組成物 |
| ES2531159T3 (es) * | 2005-07-29 | 2015-03-11 | Solasia Pharma K K | Compuestos y métodos para el tratamiento del cáncer |
| CN104109177A (zh) * | 2006-01-13 | 2014-10-22 | 得克萨斯州A&M大学系统 | 用于治疗癌症的化合物和方法 |
| TW200829261A (en) * | 2006-09-29 | 2008-07-16 | Ziopharm Oncology Inc | Method for controlling angiogenesis in animals |
-
2008
- 2008-12-12 AU AU2008335705A patent/AU2008335705A1/en not_active Abandoned
- 2008-12-12 KR KR1020107012553A patent/KR20100097679A/ko not_active Application Discontinuation
- 2008-12-12 CA CA2705467A patent/CA2705467A1/en not_active Abandoned
- 2008-12-12 CN CN201410601625.3A patent/CN104592302A/zh active Pending
- 2008-12-12 JP JP2010537963A patent/JP5600597B2/ja active Active
- 2008-12-12 BR BRPI0821002-0A patent/BRPI0821002A2/pt not_active IP Right Cessation
- 2008-12-12 CN CN200880117674A patent/CN101874034A/zh active Pending
- 2008-12-12 WO PCT/US2008/013620 patent/WO2009075870A1/en active Application Filing
- 2008-12-12 US US12/744,655 patent/US20100331403A1/en not_active Abandoned
- 2008-12-12 EP EP08860274A patent/EP2231684A4/en not_active Withdrawn
- 2008-12-12 SG SG2012087250A patent/SG186599A1/en unknown
-
2010
- 2010-04-26 IL IL205339A patent/IL205339A0/en unknown
-
2014
- 2014-08-18 JP JP2014165734A patent/JP2015063514A/ja active Pending
-
2015
- 2015-10-28 HK HK15110617.5A patent/HK1209754A1/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CN104592302A (zh) | 2015-05-06 |
| US20100331403A1 (en) | 2010-12-30 |
| WO2009075870A1 (en) | 2009-06-18 |
| EP2231684A1 (en) | 2010-09-29 |
| HK1209754A1 (en) | 2016-04-08 |
| SG186599A1 (en) | 2013-01-30 |
| IL205339A0 (en) | 2010-12-30 |
| KR20100097679A (ko) | 2010-09-03 |
| JP5600597B2 (ja) | 2014-10-01 |
| JP2015063514A (ja) | 2015-04-09 |
| JP2011506443A (ja) | 2011-03-03 |
| AU2008335705A1 (en) | 2009-06-18 |
| CN101874034A (zh) | 2010-10-27 |
| CA2705467A1 (en) | 2009-06-18 |
| EP2231684A4 (en) | 2011-09-07 |
| WO2009075870A9 (en) | 2009-10-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BRPI0921321A2 (pt) | métodos para o tratamento de indwcções e tumores | |
| BRPI0919238A2 (pt) | métodos e composições para o tratamento de câncer | |
| BRPI0810206A2 (pt) | Método de tratar câncer | |
| BRPI0818320A2 (pt) | composição para tratamento de câncer de próstata (pca) | |
| BRPI0813725A2 (pt) | Métodos e composições para tratamento de doenças | |
| BRPI0811589A2 (pt) | Composição farmacêutica e método para tratar câncer | |
| BRPI0821660A2 (pt) | Combinações de agentes terapêuticos para tratamento de câncer | |
| DK2121139T3 (da) | Formulations for cancer treatment | |
| BRPI0909164A2 (pt) | método e composições para o tratamento de câncer | |
| BRPI1007972A2 (pt) | composições de combinação e métodos para o tratamento de câncer | |
| BRPI0813670A2 (pt) | Compostos para tratamento | |
| BRPI0819076A2 (pt) | aparelho para tratamento de água | |
| BRPI0810525A2 (pt) | Composições e métodos para a profilaxia e tratamento de dependência química | |
| BRPI1008566A8 (pt) | métodos e composições para o diagnóstico e tratamento de câncer | |
| BR112012004281A2 (pt) | uso de metformina tratamento e prevenção de câncer | |
| BRPI0922884A2 (pt) | compostos para tratamento de câncer | |
| BRPI1008564A2 (pt) | métodos e composições para o dignóstico e tratamento de câncer | |
| EP2125002A4 (en) | TREATMENT OF SKIN CANCER | |
| DK2235002T3 (da) | 4-pyridinonforbindelser og anvendelse heraf til behandling af cancer | |
| BRPI0909016A2 (pt) | anticorpos úteis para o tratamento do câncer | |
| BRPI0816712A2 (pt) | terapia de intervalo para o tratamento de tinnitus | |
| BRPI1007995A2 (pt) | orto-aminoamidas para o tratamento de cãncer. | |
| DK2173831T3 (da) | Brøndbehandling | |
| BRPI0813364A2 (pt) | Métodos de diagnóstico e tratamento de câncer. | |
| BRPI0812932A2 (pt) | Composições e métodos de tratar câncer |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE AS 6A E 7A ANUIDADES. |
|
| B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2343 DE 01-12-2015 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013. |